Panel discussion and closing remarks - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?
Session:
Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?
Topic:
Oral Anticoagulation
Sponsored by Daiichi Sankyo, Europe
Event:
EHRA 2019
Congress Presentation
About the speaker
Professor Stefan H Hohnloser
Johann Wolfgang Goethe University, Frankfurt (Germany)
30
presentations
1
follower
4 more presentations in this session
Welcome and Introduction - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?
Speaker: Professor S. Hohnloser (Frankfurt, DE)
ELIMINATE-AF trial in the context of other non-vitamin K antagonist oral anticoagulant trials.
Speaker: Professor J. Kautzner (Prague, CZ)
Implications of non-vitamin K antagonist oral anticoagulant trials in ablation practice.
Speaker: Doctor M. Grimaldi (Acquaviva Delle Fonti, IT)
Current recommendation for atrial fibrillation patients undergoing ablation.
Speaker: Professor J. Steffel (Zurich, CH)
Access the full session
Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?
Speakers:
Professor S. Hohnloser, Professor S. Hohnloser, Professor J. Kautzner, Doctor M. Grimaldi, Professor J. Steffel
About the event
ESC 365 is supported by
